Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients

Conditions: Stage III Malignant Melanoma of Skin AJCC V6; Stage IV Malignant Melanoma of Skin Interventions: Biological: TAPCells vaccine Sponsors: University of Chile Completed

https://clinicaltrials.gov/study/NCT06152367

Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials